In 2007, it was first reported that there is a fusion gene in NSCLC, which comprises portions of echinoderm microtubule-associated protein-like 4 genes (EML4) and anaplastic lymphoma kinase gene (ALK) in ∼7% of patients with NSCLC. Here, ALK is linked to non-small cell lung carcinoma.